Becker's Healthcare August 15, 2023
CMS plans to soon release its list of 10 drugs that are up for price negotiations as it gears up to wield new powers granted by the Inflation Reduction Act, which passed in August 2022.
Researchers from the Washington, D.C.-based West Health Policy Center and the University of California San Diego studied which drugs might be chosen by CMS. They evaluated drug age — since only those older than a decade are eligible — Part B and Part D gross spending in 2020, and estimates of when a drug will lose its exclusivity status.
The first phase of negotiations are expected to become effective in 2026, and the researchers said the negotiations have the potential to save CMS...
Today's Sponsors
Today's Sponsor